Sponsors (2)
The bill directs modest federal funding and clearer definitions to expand research, outreach, and data-driven efforts that could improve thyroid disease detection and reduce disparities, but it increases federal spending, raises privacy and administrative burdens, and may take years to yield measurable clinical benefits.
Patients with thyroid disease (including people with thyroid cancer, women of reproductive age, and pregnant people) will get more research-backed diagnostics, treatments, and survivorship care as new federally funded research clarifies causes, long-term impacts, and best practices.
People in historically underserved groups (by race, language, geography, insurance status, sexual orientation, gender identity, and disability) will receive more targeted attention because the law requires disaggregated data, disparity assessments, and recommendations to reduce gaps in care.
Patients, clinicians, and health systems will gain better information and guidance — through public interim reports, an awareness campaign, and evidence-based clinical guidance — that can improve early detection, symptom recognition, diagnosis, and patient–provider communication.
Taxpayers will fund new federal spending (notably $30 million/year for research plus $3 million/year for outreach in FY2026–FY2030) and broader definitions could expand program costs, representing an ongoing fiscal commitment.
Collecting and analyzing sensitive demographic and health data could create privacy risks and additional reporting burden for insurers, federal plans, hospitals, and state agencies if protections and processes are not robust.
Research findings and recommendations may take years to translate into changed clinical practice, and provisions that are advisory or lack deadlines/funding could delay implementation and benefits for patients.
Based on analysis of 6 sections of legislative text.
Introduced December 18, 2025 by Haley Stevens · Last progress December 18, 2025
Requires the Department of Health and Human Services to fund and carry out multi-year research, data analysis, and public awareness work on thyroid disease, with a focus on causes, diagnostics, treatment options, cancer survivorship, and disparities across race, sex, geography, language, disability, sexual orientation/gender identity, and insurance status. Directs HHS to gather and analyze health program and survey data, consult with scientific bodies and professional societies, produce interim and final reports to Congress, and run a national awareness campaign; authorizes multi-year funding to support these activities.